ALTIMMUNE, INC.

ALT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $41.0K $20.0K $426.0K $-68.0K $4.4M $8.2M $5.8M $10.3M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development $66.4M $82.2M $65.8M $70.5M $74.5M $49.8M $17.8M $18.5M
SG&A Expense $28.1M $21.0M $18.1M $17.1M $15.4M $13.2M $8.5M $9.8M
Operating Income $-94.5M $-103.2M $-95.9M $-87.7M $-96.9M $-54.8M $-21.5M $-42.8M
Operating Margin -230,461.0% -515,860.0% -22,518.5% 129,029.4% -2,197.6% -669.5% -370.0% -414.6%
Interest Expense $35.0K $8.0K $5.0K $9.4K $2.2K $297.1K
Pretax Income $-88.8M $-95.1M $-88.4M $-84.9M $-97.1M $-54.5M $-20.6M $-45.3M
Income Tax Expense $-681.0K $-197.0K $-5.4M $-58.5K $-6.1M
Net Income $-88.1M $-95.1M $-88.4M $-84.7M $-97.1M $-49.0M $-20.5M $-39.2M
Net Margin -214,861.0% -475,295.0% -20,762.2% 124,577.9% -2,201.6% -599.2% -353.7% -379.2%
EPS (Basic) $-1.00 $-1.34 $-1.66 $-1.81 $-2.35 $-1.91 $-1.60 $-15.16
EPS (Diluted) $-1.00 $-1.34 $-1.66 $-1.81 $-2.35 $-1.91 $-1.60 $-15.16
Shares Outstanding (Basic) 88.1M 71.0M 53.2M 46.9M 41.3M 25.6M 15.3M 9.1M
Shares Outstanding (Diluted) 88.1M 71.0M 53.2M 46.9M 41.3M 25.6M 15.3M 9.1M
Dividends Per Share
← Newer Page 1 of 2 Older →